Author： Lønning Per E.
Publisher： Adis International
ISSN： 0312-5963
Source： Clinical Pharmacokinetics, Vol.42, Iss.7, 2003-01, pp. : 619-631
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Aromatase Inhibitors and Inactivators for Breast Cancer Therapy
By Lønning P.E.
Drugs & Aging, Vol. 19, Iss. 4, 2002-04 ,pp. :
Access to resources
Recommend
Comprehensive Pharmacology and Clinical Efficacy of Aromatase Inhibitors
By Njar V.C.O.
Drugs, Vol. 58, Iss. 2, 1999-08 ,pp. :
Clinical Pharmacokinetics and Pharmacodynamics of Cholinesterase Inhibitors
By Jann M.W.
Clinical Pharmacokinetics, Vol. 41, Iss. 10, 2002-01 ,pp. :
By Grubjesic Simonida Moriarty Robert M Pezzuto John M
Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 11, 2002-11 ,pp. :
Clinical Pharmacokinetics of Non-Nucleoside Reverse Transcriptase Inhibitors
By Smith P.F.
Clinical Pharmacokinetics, Vol. 40, Iss. 12, 2001-01 ,pp. :